Private Shareholders

Being a Shareholder

As a Sanofi shareholder, you own a share in our capital, providing us with the resources we need to grow. By investing in our future, you are giving us a vote of confidence. Confidence is the cornerstone of the special relationship between us and our shareholders. We are committed to retaining and building your confidence by involving you in our development and giving you a share of our profits.

Q1 2024 Financial Results

“We are off to an excellent start in 2024, delivering on our strategic priorities and a transformation of our portfolio of medicines and vaccines to become a development-driven, tech-powered biopharma company committed to serving patients and accelerating growth. Continued strong performance by Dupixent and our new launches drove sales growth of seven percent. In parallel, we are delivering on our promise of increased investments in our late-stage pipeline to fully realize its value for patients and Sanofi. We are awaiting regulatory decisions for Dupixent in COPD, a progressive disease with limited effective treatment options. If approved, Dupixent will be the first biologic treatment in COPD. With the robust progress in our portfolio transformation, we reaffirm our financial guidance for 2024.”

Paul Hudson, Chief Executive Officer

Our Pipeline

5

Therapeutic areas

77

Compounds in clinical development

28

Clinical trials in phase 3

Sanofi France – Key figures

How to Hold Sanofi Shares

Sanofi ordinary shares can be held as:

  • Bearer shares: deposited with your financial intermediary,
  • Administered registered shares: deposited with your financial intermediary and recorded in the books of Sanofi,
  • Fully registered shares: deposited with and administered by Uptevia, transfer agent appointed by Sanofi. You benefit in this case from preferential rates for brokerage fees & bank commission and double voting rights when you have held your shares for at least two years

Uptevia fees for holding pure registered securities:

  • Free custody and administration fees
  • Bank commission of 7.62 euros per order
  • Brokerage fee: 0.45% with a minimum of 6.10 euros per order
Paul Hudson speaking at the Annual General Meeting 2024
Paul Hudson speaking at the Annual General Meeting 2024

Annual General Meeting 2024

The Sanofi General Meeting was held on April 30, 2024. 

In-Depth Reading

Shares